4 0 0 0 OA 小学校給食における主食の配食状況とエネルギー摂取量の関係
- 著者
- 吉川 達哉 小林 由依 中西 朋子 樋口 良子 鈴木 志保子
- 出版者
- 神奈川県立保健福祉大学
- 雑誌
- 神奈川県立保健福祉大学誌 = Journal of Kanagawa University of Human Services (ISSN:13494775)
- 巻号頁・発行日
- vol.16, no.1, pp.25-35, 2019-03
3 0 0 0 OA 小学校給食における一人前均等配食の有効性の検討
- 著者
- 吉川 達哉 小林 由依 中西 朋子 樋口 良子 駿藤 晶子 徳永 美希 飯田 綾香 鈴木 志保子
- 出版者
- 神奈川県立保健福祉大学
- 雑誌
- 神奈川県立保健福祉大学誌 = Journal of Kanagawa University of Human Services (ISSN:13494775)
- 巻号頁・発行日
- vol.17, no.1, pp.59-70, 2020-03
3 0 0 0 OA 重複投薬・相互作用等防止加算関連業務の分析と経済効果
- 著者
- 味澤 香苗 鈴木 学 林 由依 甲斐 絢子 小林 篤史 小原 道子 生木 庸寛 國府田 真綾 金地 夏実 林 秀樹 棚瀬 友啓 土屋 照雄 杉山 正
- 出版者
- 一般社団法人日本医療薬学会
- 雑誌
- 医療薬学 (ISSN:1346342X)
- 巻号頁・発行日
- vol.44, no.12, pp.599-606, 2018-12-10 (Released:2019-12-10)
- 参考文献数
- 8
- 被引用文献数
- 6
Focusing on the Pharmaceutical Intervention Records (PIR) project conducted in collaboration with the Gifu Pharmaceutical Association and Gifu Pharmaceutical University, this study analyzed characteristics and economic effects of the audit of dispensing fees for the prevention of duplications or interactions of prescription drugs by pharmacists. The pharmacists registered audit data of 1,105 prescriptions into the PIR database in 2017. For the analysis, we divided 1,105 prescriptions into those that incurred dispensing fees for the prevention of duplications or interactions of prescription drugs (the subject group) and a control group comprising other prescriptions. The reduction in drug cost per prescription was 1,689 yen in the subject group, which was significantly higher than the reduction of 563 yen in the control group. In the subject group, pharmacists tend to use a medicine notebook for identifying duplicate administrations or drug interactions. There is a high ratio of cancellation of drugs as a result of such inquiries. This is considered a factor in the reduction of the cost of drugs. The reduction per prescription in the subject group is higher than the medical fees for the prevention of duplications or interactions of prescription drugs, and it can be evaluated that activities related to preventing duplications and interactions of prescription drugs contribute to medical economy.
